PharmGen Science Inc (004720) — Cash Flow Quality Index
PharmGen Science Inc (004720) has a Cash Flow Quality Index of 0.92x as of December 2024. Operating cash flow of ₩3.40 Billion is below net income of ₩3.71 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of PharmGen Science Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PharmGen Science Inc Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for PharmGen Science Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see PharmGen Science Inc (004720) cash flow conversion.
Annual Cash Flow Quality Index for PharmGen Science Inc (2015–2024)
Year-by-year earnings quality comparison for PharmGen Science Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.85x | ₩2.38 Billion | ₩2.79 Billion | ▼ -4.4% |
| 2023 | 0.89x | ₩5.44 Billion | ₩6.09 Billion | ▲ +4965.7% |
| 2022 | -0.02x | ₩-1.29 Billion | ₩70.06 Billion | ▼ -107.7% |
| 2021 | 0.24x | ₩7.78 Billion | ₩32.47 Billion | ▼ -17.4% |
| 2020 | 0.29x | ₩2.68 Billion | ₩9.22 Billion | ▼ -96.5% |
| 2019 | 8.36x | ₩2.52 Billion | ₩301.98 Million | ▲ +785.7% |
| 2018 | 0.94x | ₩4.22 Billion | ₩4.47 Billion | ▲ +121.8% |
| 2017 | 0.43x | ₩1.84 Billion | ₩4.32 Billion | ▼ -81.1% |
| 2016 | 2.25x | ₩7.75 Billion | ₩3.45 Billion | ▲ +28.2% |
| 2015 | 1.75x | ₩3.62 Billion | ₩2.07 Billion | — |